Patent ID: 11952386
Assignee: NOVARTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 8:
9. The compound of claim 1, or a pharmaceutically acceptable salt thereof, wherein:
Y1 is N;
Y2 is CR6;
R1 is —xR1a; wherein
R1a is a 6 member heteroaryl group containing 1 to 2 nitrogen atoms; wherein said heteroaryl is substituted with 1 to 3 R9 groups independently selected from halo, amino, C1-4alkoxy, dimethyl-amino, and halo-substituted-C1-4 alkyl;
X is S(O)m; wherein m is 0; and
R6 is hydrogen;
or a pharmaceutically acceptable salt thereof.